# A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

> **NCT00789399** · NA · TERMINATED · sponsor: **Prairie Education and Research Cooperative** · enrollment: 78 (actual)

## Conditions studied

- Deep Vein Thrombosis
- Coronary Artery Bypass Surgery
- Venous Thromboembolism

## Interventions

- **DRUG:** Fondaparinux
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00789399
- **Lead sponsor:** Prairie Education and Research Cooperative
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11-19
- **Primary completion:** 2013-09-21
- **Final completion:** 2013-09-21
- **Target enrollment:** 78 (ACTUAL)
- **Why stopped:** Principal Investigator moved to another region of the country
- **Last updated:** 2022-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789399, "A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00789399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*